Drug Enforcement D-0437-2024

Subpotent Drug

Status

Terminated

Classification

Class II

Report Date

April 17, 2024

Termination Date

April 4, 2025

Product Information

Product description
Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India, NDC 6818-0659-06
Product quantity
26,352 bottles
Reason for recall
Subpotent Drug
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide within the United States

Location & Firm

Recalling firm
Lupin Pharmaceuticals Inc.
Address
Harborplace Tower, 111 S Calvert St Fl 21st

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0437-2024
Event ID
94271
Recall initiation date
March 21, 2024
Center classification date
April 5, 2024
Code info
Lot #: A201064, Exp. Date March 2024
More code info
—